Vaasa Childhood Obesity Primary Prevention Study

Childhood Obesity Pevention Clinical Trial

— VACOPP  

Official title:

Vaasa Childhood Obesity Primary Prevention Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00970710
• Other study ID #: 100454
• Status: Completed
• Phase: N/A
• First received: September 1, 2009
• Last updated: February 12, 2017
• Start date: January 1, 2009
• Est. completion date: January 31, 2017

Study information

• Verified date: February 2017
• Source: University of Tampere
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to prevent childhood obesity with early life (pregnancy) intensified counselling. The recruited intervention group is pregnant mothers who are at risk to get gestational diabetes. Lifestyle intervention (nutritional and physical activity) begins during pregnancy in maternity clinics and continues in child wellfare clinics until the child is 5 years of age.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 185
• Est. completion date: January 31, 2017
• Est. primary completion date: January 31, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A to 6 Years

Eligibility

Inclusion Criteria:

• Pregnant women who are at risk to get gestational diabetes.

Exclusion Criteria:

• Foreigner with language problems

• Major psychosocial problems

• Diabetes mellitus type I or II

• Physical disability,

• Major medical problems in pregnancy

Related Conditions & MeSH terms

• Childhood Obesity Pevention
• Obesity
• Pediatric Obesity

Intervention

Behavioral:
• Vaasa Childhood Obesity Primary Prevention Study
Intensified counselling concerning healthy diet and suitable physical activity during pregnancy to mothers in the intervention group continuing in child health care clinic visits with the offspring until child's age of 5 year.

Locations

Country	Name	City	State
Finland	Health care center in Vaasa	Vaasa

Sponsors (5)

Lead Sponsor	Collaborator
University of Tampere	Foundation for Paediatric Research, Finland, Seinajoki Central Hospital, Tampere University Hospital, Vaasa Health care center

Country where clinical trial is conducted

Finland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Preventing childhood obesity	Difference in offspring weight gain compared to control group	Offspring age until six years
Secondary	lower cholesterol values		up to six years
Secondary	lower HOMA-index		up to six years